Skip to content

20+ Years of Healthcare Transformation

About VigiLanz

Founded in 2001 in Minneapolis, Minnesota, VigiLanz is a privately held provider of SaaS-based clinical surveillance and patient safety technology. Our experienced teams deeply understand the challenges of working on the frontlines of healthcare – and we are committed to empowering clinicians with the real-time data they need to prevent harm, improve safety, and provide the highest quality patient care.

VigiLanz is a clinical partner to a large and growing community of hospital CMOs, CMIOs, CIOs, quality and safety teams, infectious disease and control specialists, pharmacists, and other clinicians dedicated to innovative, real-time inpatient and outpatient care. From pharmacy and infection prevention to patient safety and quality, we are proud to support some of the best hospitals in the United States with our award-winning products.

Our Mission

To advance the delivery of data-driven patient care.

Our Vision

To help all patients and clinicians thrive.

Join Us

Explore open career opportunities and help us revolutionize the future of patient care.

For more than 20 years, VigiLanz has put patient safety and wellbeing at the heart of everything we do, and we remain committed to providing our pharmacists, infection preventionists, researchers, and safety professionals with the tools and the support you need to make a difference at your hospitals. We are so proud of the work you are doing.

Hayley Burgess, Chief Operating Officer + Chief Clinical Officer, VigiLanz

Board of Directors

David Goldsteen Chairman

Dr. Goldsteen is the co-founder of VigiLanz, and serves as Chairman and CEO. He is a founder and former Chairman and CEO of Vascular Science, Inc., purchased by St. Jude Medical (NASDAQ:STJ). He is the founder and Managing Partner of Global Capital Investments, LLC, a boutique merchant banking group. He previously served as a board member/financier of SurVivaLink, a medical device manufacturer sold to Cardiac Science (NASDAQ:DFIB), MediaDVX, a digital media provider sold to NetStar LP, InfoPet, a veterinary microchipping company, and Quantech, Ltd, a medical diagnostics company. From 1988–1993 he served as Vice President of Medical Affairs for Emergency Services at Health One, a predecessor of Allina Hospitals and Clinics, a diversified healthcare delivery organization. Dr. Goldsteen is a graduate of the University of Minnesota Medical School, performing his residency in Internal Medicine at Hennepin County Medical Center in Minneapolis, MN. He received board certifications in internal medicine and emergency medicine. He received his M.B.A. in 1994 from the Carlson School of Management at the University of Minnesota.

David Abelson Director

David Abelson, MD has had a career in medicine, health system design, and executive leadership. David trained in general internal medicine and after a time in private practice joined a large integrated delivery system, Park Nicollet Health Services. In 2010 David became CEO of Park Nicollet Health Services and led the direction of Park Nicollet to value-based payment resulting in a merger with HealthPartners in 2013. As Senior Vice President of HealthPartners and CEO of Park Nicollet, David led a delivery system with multiple hospitals, clinics and specialties with a combined annual revenue of $2.2 billion. David retired in 2014 and is now President of the Institute for Clinical Systems Improvement.

Jeff Zalasky Director

Jeff Zalasky, JD served as General Counsel for VigiLanz until his retirement in 2014 and currently serves as an observer of the board of directors. He is a vice president of Global Capital Investments, LLC, a boutique merchant banking group. Jeff served on the board of Vascular Science, Inc. prior to its acquisition by St. Jude Medical in 1999, and he was a board observer for MediaDVX. Jeff received his law degree from Hamline University School of Law in St. Paul, Minnesota.

David Klass Observer

Dr. Klass is the developer of VigiLanz’s prototype technology and served as Chief Medical Officer from the company’s founding in 2001 through his retirement in 2014. He has had a long-term interest in the logic of pharmacy ordering systems and the relation of these systems to laboratory results and the creation of tools that could mine and combine both systems intelligently. Dr. Klass graduated from the University of Manitoba and the University of Chicago. He lives in Spain and Chicago.

David Orbuch Director

David Orbuch is a values-based leader that has successfully led businesses on three continents. David achieves results by leveraging the power of strong and diverse teams, relentlessly focusing on operational excellence, and recognizing that a healthy corporate culture is a sustainable competitive advantage. His core leadership strengths include, financial management, strategy development, business planning, and operational execution. David is also a recognized leader in the area of governance, corporate responsibility and health care compliance